LAURENT PHARMACEUTICALS INC. is an active federal corporation (corporation number 8361924). Its business number is 835517442. It was incorporated on Nov 29, 2012 under the Canada Business Corporations Act and its registered office is in Montreal, Quebec. Its annual returns are up to date, most recently for 2025. It has three directors on record.
Corporate details
- Corporation number
- 8361924
- Business number
- 835517442
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Nov 29, 2012
- Corporation type
- Non-distributing corporation with more than 50 shareholdersAs declared in its 2021 annual return.
- Registered office
- 2401-1010 Rue Sherbrooke Ouest
Montréal QC H3A 2R7 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Nov 29The date of incorporation, amalgamation or continuance.
- Annual filing period
- Nov 29 to Jan 28 each year
- Last annual meeting
- Mar 11, 2021
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Not yet due Due from Nov 29, 2026 | |
| 2025 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
6 agreements since 2019, worth $17,776,036 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | LAU-7b as next-generation COVID-19 therapeutic - COVID-19 Response-Stage 3 (TI): antiviral & Inflammation Controlling Therapeutic Drug Clinical Evaluation | $7,000,000 | Feb 1, 2023 |
| National Research Council Canada | Innovation Assistance Program – Round 2.5 | $21,676 | Dec 20, 2020 |
| National Research Council Canada | COVID-19 Response (TI): antivrial & Inflammation Controlling Therapeutic Drug Clinical Evaluation | $10,000,000 | Oct 1, 2020 |
| National Research Council Canada | Innovation Assistance Program – Round 2 | $48,704 | Jun 25, 2020 |
| National Research Council Canada | Innovation Assistance Program | $40,656 | Apr 1, 2020 |
| National Research Council Canada | Formulation optimization and scale-up preclinical proof-of-principle in multiple animal models of rare diseases | $665,000 | Oct 1, 2019 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| LAURENT PHARMACEUTICALS INC. | Name | Dec 20, 2012 |
Filings and certificates
| What | Date |
|---|---|
| Proxy | May 22, 2025 |
| Proxy | Mar 11, 2024 |
| Proxy | Feb 29, 2024 |
| Proxy | May 17, 2023 |
| Proxy | Mar 3, 2022 |
| Proxy | Mar 1, 2022 |
| Proxy | Mar 9, 2021 |
| Proxy | Mar 1, 2021 |
| Proxy | Mar 10, 2020 |
| Articles amended | Sep 4, 2018 |
| Incorporated | Nov 29, 2012 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.